Avalon GloboCare Board Director Highlights RPM Interactive’s Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com
Rhea-AI Summary
Avalon GloboCare (NASDAQ: ALBT) announced the acquisition of RPM Interactive and highlighted RPM CEO and Avalon board member Michael Mathews discussing RPM’s Catch-Up generative AI video platform in a Dec. 30, 2025 interview.
Catch-Up is described as a SaaS platform that automatically generates recap-style videos using generative AI and large language models, planned for licensing to content creators, media companies and brands across news, sports, finance, entertainment and other categories. Avalon intends to use the platform to support marketing for KetoAir, its FDA-registered breathalyzer for metabolic wellness. The interview is available on ProactiveInvestors.com and on YouTube.
Positive
- Acquisition of RPM Interactive announced on Dec. 30, 2025
- Catch-Up described as an automated generative AI SaaS video platform
- Platform planned to be licensed to content creators, media companies, brands
- Avalon plans to leverage Catch-Up to market KetoAir breathalyzer
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus 1 Up
Peers showed mixed moves: LRHC up 5.48%, WETH down 3.36%, GBR up 1.36%, DUO down 1.26%. Momentum scanner only flagged DUO earlier up 6.37% without news, suggesting ALBT’s AI platform update is stock-specific rather than part of a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 15 | AI acquisition | Positive | -24.6% | All-stock acquisition of RPM Interactive to add generative AI video SaaS. |
| Dec 01 | Operational update | Positive | -8.1% | Q3 progress on KetoAir™, holistic health programs, and UK expansion. |
| Aug 28 | Product launch | Positive | +2.9% | Announcement of KetoAir™ online launch in the UK on Sept 1, 2025. |
| Jul 28 | Distribution deal | Positive | +30.8% | Distribution agreement with Saga Health for KetoAir™ targeting first responders. |
| Jul 14 | Patent issuance | Positive | +6.3% | New Hong Kong patent for bispecific CAR-T and CAR-NK immunotherapy tech. |
Commercial and partnership news around KetoAir™ and IP wins have often led to positive moves, while the recent RPM AI acquisition and Q3 operational update saw negative price reactions despite constructive narratives.
Over the last six months, Avalon has pivoted toward consumer metabolic health and AI-enabled marketing. KetoAir™ commercialization advanced through a UK launch on Sept 1, 2025 and a first‑responder distribution deal, both met with positive price reactions. A Hong Kong CAR‑T/CAR‑NK patent win also supported shares. By contrast, the Dec 15 all‑stock RPM AI acquisition and the Q3 2025 progress update prompted selloffs, showing investor sensitivity to financing structure and execution risk as Avalon layers AI capabilities onto its KetoAir™ strategy.
Market Pulse Summary
This announcement reinforces Avalon’s effort to integrate RPM’s generative AI Catch-Up SaaS platform into its consumer health strategy, particularly for marketing KetoAir™, its FDA-registered breathalyzer. Recent history shows meaningful moves around KetoAir™ launches and distribution deals, while the RPM acquisition drew a negative reaction. Investors may watch how effectively the AI video tools drive KetoAir™ adoption relative to the company’s ongoing operating losses of $15.94 million in the first half of 2025.
Key Terms
generative artificial intelligence technical
saas technical
large language models technical
fda-registered regulatory
AI-generated analysis. Not financial advice.
FREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that Michael Mathews, a member of the Company’s Board of Directors and Chief Executive Officer of RPM Interactive, Inc. (“RPM”), participated in an interview with Proactiveinvestors.com. Recently, the Company announced that it has acquired RPM Interactive, Inc. (“RPM”), a generative artificial intelligence (“AI”) publishing and software company.
During the interview, Mr. Mathews discussed the development of the Catch-Up platform, highlighting its position as a SaaS platform capable of automatically generating videos using generative AI applications and large language models. He also outlined the platform’s marketing strategy and upcoming commercialization plans.
The Catch-Up SaaS platform is expected to be licensed to content creators, media companies, and brands to efficiently generate recap-style videos across news, politics, sports, finance, entertainment, and other evergreen categories—without requiring manual editing, production tools, or technical expertise. This unique video format has been designed to give content creators a second video format to publish with, and is intended to help drive up their volume of videos produced each week.
Avalon plans to leverage the Catch-Up platform to support and amplify marketing initiatives for KetoAir™, a FDA-registered breathalyzer marketed by Avalon, which is designed to help consumers monitor and manage their wellness and metabolic health.
The interview can be viewed on ProactiveInvestors.com and on their YouTube channel:
https://www.youtube.com/watch?v=sTr1DjvFyCI&t=455s
About Avalon GloboCare Corp.
Avalon GloboCare Corp. (NASDAQ: ALBT) is a developer of precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. Avalon is currently marketing the KetoAir™ breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAirTM is registered with the U.S. Food and Drug Administration as a Class I medical device. The Company also continues to focus on advancing its intellectual property portfolio through existing patent applications. In addition, Avalon owns and operates commercial real estate.
For more information about Avalon, please visit www.avalon-globocare.com. Information on the Company’s website does not constitute a part of and is not incorporated by reference into this press release.
No Offer or Solicitation
This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any proxy, consent, authorization, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the “Securities Act”).
Additional Information About the Proposed Merger for Investors and Shareholders
This communication relates to the proposed merger (the “proposed Merger”) of Avalon and YOOV Group Holding Limited (“YOOV”). In connection with the proposed Merger, Avalon has filed relevant materials with the U.S. Securities and Exchange Commission (the “SEC”), including a Registration Statement on Form S-4, as amended, that contains a preliminary prospectus and preliminary proxy statement of Avalon (the “proxy statement/prospectus”). This Registration Statement has not yet been declared effective and Avalon has filed or may file other documents regarding the proposed Merger with the SEC. This press release is not a substitute for the proxy statement/prospectus or for any other document that Avalon has filed or may file with the SEC in connection with the proposed Merger. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY, WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT STOCKHOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING THE PROPOSED MERGER. A definitive proxy statement/prospectus will be sent to Avalon’s stockholders. Investors and security holders will be able to obtain these documents (when available) free of charge from the SEC’s website at www.sec.gov. In addition, investors and stockholders should note that Avalon communicates with investors and the public using its website (https://www.avalon-globocare.com), the investor relations website (https://www.avalon-globocare.com/investors) where anyone will be able to obtain free copies of the proxy statement/prospectus and other documents filed by Avalon with the SEC, and stockholders are urged to read the proxy statement/prospectus and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed Merger.
Participants in the Solicitation
Avalon, YOOV and their respective directors and executive officers and other members of management and employees and certain of their respective significant stockholders may be deemed to be participants in the solicitation of proxies from Avalon and YOOV stockholders in respect of the proposed Merger. Information about Avalon’s directors and executive officers is available in Avalon’s Form 10-K for the fiscal year ended December 31, 2024, which was filed with the SEC on March 31, 2025. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the proxy solicitation and a description of their direct and indirect interests, by security holding or otherwise, has been and will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed Merger when they become available. Investors should read the definitive proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the SEC and Avalon as indicated above.
Forward-Looking Statements
Certain statements contained in this press release are “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve several risks and uncertainties. You can identify these statements by the fact that they use words such as “will”, “anticipate”, “estimate”, “expect”, “should”, “may”, and other words and terms of similar meaning or use of future dates; however, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, including statements regarding the ability to enter into a definitive agreement, as well as the Company’s commercialization, distribution and sales of its products and the product’s ability to compete with other similar products. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission (the “SEC”), accessible through the SEC’s website (http://www.sec.gov), including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K filed or furnished with the SEC. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors, including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. The Company disclaims any obligation to update forward-looking statements. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release. The contents of any website referenced in this press release are not incorporated by reference herein.
Contact Information:
Avalon GloboCare Corp.
4400 Route 9 South, Suite 3100
Freehold, NJ 07728
PR@Avalon-GloboCare.com
Investor Relations:
Crescendo Communications, LLC
Tel: (212) 671-1020 Ext. 304
albt@crescendo-ir.com
FAQ
What did Avalon GloboCare (ALBT) announce on December 30, 2025?
What is the Catch-Up platform that ALBT acquired via RPM Interactive?
How does Avalon plan to use the Catch-Up platform for KetoAir marketing?
Who is Michael Mathews in relation to Avalon GloboCare (ALBT)?
Which audiences is the Catch-Up platform targeted to license to by ALBT?
Where can investors watch the interview about ALBT’s acquisition and Catch-Up platform?
